Provenance du réseau au premier degré de Simon Wheeler
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 9 | |
Roslin Technologies Ltd.
Roslin Technologies Ltd. BiotechnologyHealth Technology Roslin Technologies Ltd. engages in the provision of agriculture biotechnology solutions. It offers genome sequencing, genotyping, gene editing, transgenics, phenotyping, and bioinformatics. The company is headquartered in Midlothian, the United Kingdom.
1
| Holding Company | Biotechnology | 1 |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz.
1
| Subsidiary | Investment Managers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Simon Wheeler via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Apaxen SA
Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Founder Director/Board Member | |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neuromedia SA | Director/Board Member | ||
NeuVasQ Biotechnologies SA
NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke. | Pharmaceuticals: Major | Director/Board Member | |
Gepeceron SARL | Director/Board Member | ||
Institut Supérieur de l'Aéronautique et de l'Espace | College/University | Graduate Degree | |
Investsud SA
Investsud SA Investment ManagersFinance INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium. | Investment Managers | Private Equity Investor | |
Caselia SA
Caselia SA HomebuildingConsumer Durables Caselia SA is a Belgian company that specializes in real estate property development and building construction services. The private company is based in Oudergem, Belgium and has subsidiaries in France. Caselia was founded in 2007 and Louis Amory has been the CEO of the company since 2020. | Homebuilding | Director/Board Member | |
University of Liege | College/University | Doctorate Degree | |
Funny Mountain SA | Director/Board Member | ||
HEC-ULG Management School | College/University | Graduate Degree | |
Université Catholique de Louvain | College/University | Doctorate Degree | |
JB Equity Ltd.
JB Equity Ltd. Investment ManagersFinance JB Equity Ltd (JB Equity) is a private equity firm which was founded in 2013 by Kristian Bennetsen and Martin Hjorth Jensen. The firm is located in Edinburgh, United Kingdom. | Investment Managers | Chairman | |
Good Dog Food Ltd.
Good Dog Food Ltd. Food: Specialty/CandyConsumer Non-Durables Good Dog Food Ltd. provides food for pets. The company is based in London, UK and was founded in 2021. | Food: Specialty/Candy | Director/Board Member | |
Faculté Polytechnique de Mons | College/University | Undergraduate Degree | |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
University of Zurich /Venture Capital/
University of Zurich /Venture Capital/ Investment ManagersFinance Novartis Venture Funds is a Venture Capital firm, a subsidiary of Novartis AG founded in 1996. Novartis Venture Funds is headquartered in *. | Investment Managers | Director/Board Member | |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus Investment Funds is a venture capital firm founded in 2003. The firm headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
Pensionnat Henri Jaspar | Director/Board Member | ||
Hôpital Erasme
Hôpital Erasme Hospital/Nursing ManagementHealth Services Part of Université Libre de Bruxelles, Hôpital Erasme is a medical facility located in Brussels, Belgium. The hospital offers polyclinics in Nivelles and Brussels, as well as specialized centers in psychiatry, geriatrics, and traumatology. | Hospital/Nursing Management | Corporate Officer/Principal | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pepric NV
Pepric NV Miscellaneous Commercial ServicesCommercial Services Pepric NV develops imaging technology. It offers sensitive imaging systems with a long observation window for in-vivo molecular and functional imaging addressing pharmaceutical applications in drug development, pre-clinical testing, diagnostic imaging and translational medicine in general. The company was founded Stephanie Laura Gerard Claire Teughels in 2009 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Corporate Officer/Principal | |
Glob-Co SRL | Director/Board Member | ||
ProSkelia BV | Founder | ||
ViroVet NV
ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
Ghent University | College/University | Doctorate Degree | |
AnimAb BV
AnimAb BV BiotechnologyHealth Technology AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020. | Biotechnology | General Counsel | |
Flanders Vaccine | Director/Board Member | ||
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Solvay Business School of Economics & Management | College/University | Undergraduate Degree |
Statistiques
Internationale
Belgique | 27 |
Etats-Unis | 3 |
France | 3 |
Royaume-Uni | 3 |
Suisse | 3 |
Sectorielle
Health Technology | 11 |
Consumer Services | 9 |
Finance | 5 |
Commercial Services | 4 |
Consumer Durables | 2 |
Opérationnelle
Director/Board Member | 21 |
Corporate Officer/Principal | 8 |
Founder | 5 |
Graduate Degree | 4 |
Doctorate Degree | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Simon Wheeler
- Connexions Sociétés